Achieve Life Sciences, Inc., was founded in October 1991, and OncoGenex Technologies was founded in May 2000. The Company is a clinical-stage pharmaceutical company dedicated to the global development and commercialization of cytisiniclines for smoking cessation and nicotine addiction. With more than 1 billion people using tobacco worldwide and more than 28 million adults smoking in the United States alone, smoking remains the leading cause of preventable disease and death, killing more than 8 million people worldwide each year. The company's primary focus is on responding to this global pandemic. 

Expected P&L on Expiry

Key Stats

Pricing Model

About ACHV20260515P2.5